T cells - 3 News by ETH Zürich
Immune-cell booster for cancer patients
“This would make it possible to administer cells from any donor to any patient” - Spin-off company planned
20-Mar-2023 - Cancer patients might one day benefit from being administered immune cells from healthy donors. But as things stand, receiving donor cells can cause severe or even fatal immune reactions. A researcher at ETH Zurich has now developed a technology that avoids these. Edo Kapetanovic is a medical ...
Redundancies in T cells
19-Jun-2019 - Researchers at ETH Zurich have discovered redundancies in the biochemical signalling pathways of immune cells. This finding has important implications for advances in cancer immunotherapy, among other areas. Oncologists have had great success with cancer immunotherapy in recent years, especially ...
Major step towards individual cancer immunotherapy
ETH spin-off founded for commercial further development of technique
02-Apr-2019 - Medicine has great hopes for personalised cancer immunotherapy. The idea is to have a vaccine prompt the immune system to fight a tumour. Scientists at ETH Zurich have developed a method that allows them to determine which molecules are suited to patient-specific immunisation. Cells belonging to ...
Haven't found the right news yet?
The bionity.com news search
Start your targeted search now with a wide range of filter options. Our database includes an archive of 25,055 life science news from business and science, which you can search by topic and organization, filtered by time and geography.